Status:
COMPLETED
PrOgnosis Following Esophageal FisTula FormaTion in Pts Undergoing CathetER Ablation for AF Study
Lead Sponsor:
University of Luebeck
Conditions:
Atrial Fibrillation
Atrio-Oesophageal Fistula
Eligibility:
All Genders
Brief Summary
Pulmonary vein isolation emerged as an effective and safe strategy to treat atrial fibrillation patients. Atrio-oesophageal fistula (AOF) represents a rare but devastating complication of AF ablation ...
Detailed Description
Data about the incidence, optimal management and outcome of AOF is sparse. The largest national and international surveys report on less than 50 AOF. The latest worldwide survey was conducted in 2015 ...
Eligibility Criteria
Inclusion
- Atrio-oesophageal fistula after Ablation
- Indication for AF ablation as per current guidelines
- Performing the ablation at an ablation centre
Exclusion
- No Atrio-oesophageal fistula after Ablation
Key Trial Info
Start Date :
March 31 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2024
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT05273645
Start Date
March 31 2022
End Date
February 28 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinik für Rhythmologie
Lübeck, Schleswig-Holstein, Germany, 23538